From on Medscape

Coverage from the

Hypertension Scientific Sessions (HYP) 2023

September 07 - 10, 2023; Boston, Massachusetts

September 07 - 10, 2023 Boston, Massachusetts
  • HYP 2023 'New Dawn' for Aldosterone as Drug Target in Hypertension? Treatment with the aldosterone synthase inhibitor lorundrostat significantly decreased automated office systolic blood pressure in adults with uncontrolled hypertension in the phase 2 TARGET-HTN trial.

Conference News

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from HYP 2022

Previous Coverage

Related Resource